Reagenti e strumenti per immunologia, biologia cellulare e biologia molecolare
Entra
Hai dimenticato la password?
Registrati
fr
en
es
de
it
pt
nl
0
0
Visualizza Carrello
Catalogo
Area di ricerca
Diagnostica
Servizi personalizzati
CRO services
Risorse tecniche
Promozioni
Contatti
Reagenti e strumenti per immunologia, biologia cellulare e biologia molecolare
Risultati della ricerca : 11 prodotto(i) trovato(i)
Limita la ricerca :
RUO
CE / IVD
Class (1)
Biochemicals
Application (1)
WB
8
APPLICARE I FILTRI
REINIZIALIZZARE
CONDIVIDI QUESTA RICERCA
COPIATO
10
20
50
100
200
500
Cat#
Descrizione
Cond.
Priced
MBS2086208-0,01mg
OVA conjugated Epidermal Growth Factor (EGF)
0.01mg
MBS2086208-0,2mg
OVA conjugated Epidermal Growth Factor (EGF)
0.2mg
MBS2086208-0,1mg
OVA conjugated Epidermal Growth Factor (EGF)
0.1mg
MBS2086208-1mg
OVA conjugated Epidermal Growth Factor (EGF)
1mg
MBS2086208-0,5mg
OVA conjugated Epidermal Growth Factor (EGF)
0.5mg
MBS2086208-5mg
OVA conjugated Epidermal Growth Factor (EGF)
5mg
MBS2086208-5x5mg
OVA conjugated Epidermal Growth Factor (EGF)
5x5mg
MBS2086208-0,05mg
OVA conjugated Epidermal Growth Factor (EGF)
0.05mg
orb1910500-1g
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
1g
orb1910500-100mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
100mg
orb1910500-250mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
250mg
‹
›